trending Market Intelligence /marketintelligence/en/news-insights/trending/bpvytcbgxxxkr1npxmrhzw2 content esgSubNav
In This List

Thermo Fisher acquires private DNA profiling company

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Thermo Fisher acquires private DNA profiling company

Thermo Fisher Scientific Inc. acquired IntegenX Inc., a Pleasanton, Calif.-based provider of rapid DNA testing tools.

Financial terms of the deal were not disclosed.

Prosecutors and law enforcement in 17 countries use IntegenX's platform, Thermo Fisher said in a news release. The Waltham, Mass.-based life sciences company plans to combine IntegenX technology with its own chemistries to help expand its position in the human identification market, in addition to enhancing its existing human identification portfolio.

Rapid DNA platforms can produce standardized profiles in less than two hours, simplifying and accelerating forensic processes.